Auger-Electron Spectra of Radionuclides for Therapy and Diagnostics
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 35 (7) , 863-868
- https://doi.org/10.3109/02841869609104038
Abstract
The present paper documents the calculation of radiation spectra and of radial dose distribution around a point source for 24 selected radionculides. The radionculides were ordered into three groups: Nuclides potentially useful for therapy by emission of Auger electrons: 51Cr, 64Cu, 67Ga, 73Se, 75Se, 77Br 80Br, 94Tc, 99mTc, 114mIn, 115In, 123I, 124I, 125I, 167Tm, 193mPt, and 195mPt, nuclides potentially useful for therapy by α-particles with additional emission of Auger electrons: 212Bi, 211At and 255Fm, and nuclides potentially useful for electron Auger-therapy with simultaneous PET diagnosis: 73Se, 94Tc and 124I. The calculations imply strongly the development of labelled DNA-seeking compounds useful as carrier for the Auger- and Coster-Kronig electron-emitting radionuclides.Keywords
This publication has 19 references indexed in Scilit:
- Selection of radionuclides for radioimmunotherapyMedical Physics, 1993
- Radiation spectra for Auger‐electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6Medical Physics, 1992
- A simplified approach to alpha dosimetry for small spheres labelled on the surfacePhysics in Medicine & Biology, 1990
- Platinum distribution inintraperitoneal tumors afterintraperitoneal cisplatin treatmentCancer Chemotherapy and Pharmacology, 1990
- Rapid communicationInternational Journal of Radiation Biology, 1990
- IN-VIVO RADIOTOXICITY OF DNA-INCORPORATED 125I COMPARED WITH THAT OF DENSELY IONISING ALPHA-PARTICLESThe Lancet, 1989
- Preliminary observations of malignant melanoma therapy using radiolabeled alpha-methyltyrosineJournal of Surgical Oncology, 1988
- Use of an 125I-labelled DNA ligand to probe DNA structureNature, 1983
- Range of Radiochemical Damage to DNA with Decay of Iodine-125Science, 1981
- Potential future application with therapeutic agentsSeminars in Nuclear Medicine, 1979